NASDAQ · Medical - Devices

PROCEPT BioRobotics Corporation (PRCT) Stock

$17.90 -0.06% NASDAQ: PRCT Healthcare

Valuation

MetricValue
Price$17.90
Market Cap$1.02B
P/E Ratio-9.39
P/B Ratio3.03
P/S Ratio3.07
EPS (TTM)$-1.72
52-Week High$38.11
52-Week Low$16.66
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-30.62%
ROA-22.90%
ROCE-27.51%
Gross Margin62.98%
Operating Margin-33.86%
Net Margin-32.54%
Debt/Equity0.23
Current Ratio6.82

Annual Financials (USD)

Metric20212022202320242025
Revenue$34.0M$75.0M$136.0M$224.0M$308.0M
Operating Profit$-54.0M$-81.0M$-109.0M$-97.0M$-104.0M
Net Profit$-60.0M$-87.0M$-106.0M$-91.0M$-96.0M
EPS$-1.37$-1.96$-2.24$-1.75$-1.72
Op Margin-157.1%-107.6%-80.2%-43.0%-33.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$337.0M$309.0M$405.0M$534.0M$508.0M
Total Liabilities$70.0M$112.0M$124.0M$132.0M$142.0M
Cash$304.0M$223.0M$257.0M$334.0M$287.0M
Borrowings$54.0M$77.0M$79.0M$80.0M$78.0M

Latest News

Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors GlobeNewswire · Jul 15, 2026 PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026 GlobeNewswire · Jul 14, 2026 Truist Downgrades PROCEPT BioRobotics to Hold From Buy, Lowers Price Target to $25 From $30 MT Newswires · Jul 6, 2026 Evercore Initiates PROCEPT BioRobotics (PRCT) At “Outperform,” Cites Aquablation Growth Potential Insider Monkey · Jun 30, 2026 Establishment Labs® Appoints Taylor Harris to Board of Directors Business Wire · Jun 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-57.0M$-80.0M$-108.0M$-99.0M$-49.0M
Investing Cash Flow$-1.0M$-5.0M$-50.0M$-9.0M$-19.0M
Financing Cash Flow$5.0M$2.0M$6.0M$16.0M$0
Net Cash Flow$204.0M$-79.0M$35.0M$77.0M$-47.0M
Free Cash Flow$-58.0M$-83.0M$-133.0M$-104.0M$-58.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.43
EV / EBITDA-8.96
FCF Yield-12.15%
Quick Ratio5.35
Interest Coverage-32.89
Return 1Y-70.78%
Return 3Y-51.39%
Return 5Y—

Ownership

Insiders Held3.17%
Institutions Held102.45%
Institutions Float Held105.80%
Institutional HolderSharesReport Date
Blackrock Inc.4,362,0022026-03-31
T. Rowe Price Investment Management, Inc.3,273,7942026-03-31
BNP Paribas Asset Management Holding S.A.3,089,3782026-03-31
Vanguard Portfolio Management LLC2,421,3622026-03-31
Vanguard Capital Management LLC2,399,0672026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CLPTClearPoint Neuro Inc. $10.49 -1.59% -12.57 $314.59M 0.00%
FOCLEDAP TMS S.A. American Depositary Shares $4.13 -1.55% -3.97 $154.61M 0.00%
MBOTMicrobot Medical Inc. $1.07 -4.46% -4.45 $48.76M 0.00%
SSIISS Innovations International Inc. $2.63 -4.01% -40.95 $526.35M 0.00%

About PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corporation is led by CEO Larry L. Wood, employs 756 people, headquartered in US, publicly traded since 2021.

PROCEPT BioRobotics Corporation (PRCT) stock trades at $17.90 with a market capitalization of $1.02B. The stock is valued at a price-to-earnings (P/E) ratio of -9.39, price-to-book of 3.03, price-to-sales of 3.07. Over the past 52 weeks the stock has ranged between $16.66 and $38.11, and currently trades 53.0% below its 52-week high.

On profitability, PROCEPT BioRobotics Corporation generates a return on equity (ROE) of -30.62%, return on capital employed of -27.51%, an operating margin of -33.86%, a net profit margin of -32.54%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides